IP Library Granted Patent US 8,501,872
Granted Patent B2
US 8,501,872 · App. 13/611,083 · Granted Aug 6, 2013

Curable fluoroelastomer compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,872
App. No.
13/611,083
Granted
Aug 6, 2013
Kind
B2
Abstract

This invention relates to curable fluoroelastomer compositions comprising a) fluoroelastomers having either nitrile, alkyne or azide cure sites and b) fluorinated curatives containing diazide, dinitrile or dialkyne groups for reacting with cure sites on the fluoroelastomer. Fluoroelastomers having azide cure sites form crosslinks with curatives having dinitrile or dialkyne groups. Fluoroelastomers having nitrile or alkyne cure sites form crosslinks with curatives having diazide groups.

Claims (9)

1. A curable composition comprising

A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of azide, sulfonyl azide and carbonyl azide groups; and

B) a curative having the formula X—(CH 2 ) n —R—(CH 2 ) m —X, wherein X is an alkyne group or a nitrile group, n, m are independently 1 to 4, and R is selected from the group consisting of i) a C 3 -C 10 fluoroalkylene group, ii) a C 3 -C 10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin.

2. A curable composition of claim 1 wherein said cure site monomer is a sulfonyl azide selected from the group consisting of CF 2 ═CFOCF 2 CF(CF 3 )OCF 2 CF 2 —SO 2 N 3 ; CF 2 ═CFOCF 2 CF 2 —SO 2 N 3 ; CF 2 ═CFOCF 2 CF 2 CF 2 —SO 2 N 3 ; and CF 2 ═CFOCF 2 CF 2 CF 2 CF 2 —SO 2 N 3 .

3. A curable composition of claim 1 wherein said cure site monomer is CF 2 ═CFOCF 2 CF(CF 3 )OCF 2 CF 2 —CON 3 .

4. A curable composition of claim 1 wherein said fluoroelastomer further comprises copolymerized units of at least one additional monomer, different from said first monomer and said cure site monomer, wherein said additional monomer is selected from the group consisting of fluorine-containing olefins, fluorine-containing vinyl ethers and hydrocarbon olefins.

5. A curable composition of claim 4 wherein said additional monomer is a fluoroolefin selected from the group consisting of vinylidene fluoride; hexafluoropropylene; tetrafluoroethylene; 1,2,3,3,3-pentafluoropropene; 1,1,3,3,3-pentafluoropropene; 3,3,3-trifluoropropene; chlorotrifluoroethylene and vinyl fluoride.

6. A curable composition of claim 4 wherein said additional monomer is a perfluoro(alkyl vinyl ether).

7. A curable composition of claim 1 wherein said curative is selected from the group consisting of NC—(CF 2 ) n —CN and HC≡C—(CF 2 ) n —C≡CH wherein n is an integer between 2 and 20.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2018
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: THE CHEMOURS COMPANY FC, LLC
Reel/Frame 045845/0913 →
SECURITY AGREEMENT Recorded Jun 10, 2015
From: THE CHEMOURS COMPANY FC LLC; THE CHEMOURS COMPANY TT, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 035839/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2015
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: THE CHEMOURS COMPANY FC, LLC
Reel/Frame 035432/0023 →